Live Breaking News & Updates on Pulmonary Artery Denervation

Stay updated with breaking news from Pulmonary artery denervation. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Pulnovo Medical Reports Positive One-year Results for PADN-CFDA Trial in Pulmonary Arterial Hypertension (PAH) Treatment

/PRNewswire/ Pulnovo Medical Limited, a globally recognized OTM platform, announced positive one-year results from the Pulmonary Artery Denervation. ....

United States , Chen Shaoliang , Pulnovo Medical , American Cardiovascular Research Technologies , World Health Organization , First Hospital Of Nanjing Medical University , Pulnovo Medical Limited , Pulmonary Artery Denervation , Cardiovasc Interv , Nanjing First Hospital , Nanjing Medical University , Professor Chen Shaoliang ,

Pulnovo Medical Inhales Tens of Millions Dollars Funding to Accelerate Global Growth

/PRNewswire/ Pulnovo Medical Limited, a globally recognized OTM (From Operating Table to Market) innovative platform, today announced the successful close. ....

Cynthia Chen , China National Medical Products Administration , Orbimed Healthcare Fund Management , Prnewswire Pulnovo Medical , Medical Limited , From Operating Table , Yuanbio Venture Capital , Cenova Capital , Lilly Asia Ventures , Gaorong Capital , Huihe Capital , Pulmonary Artery Denervation , Global Trial , National Medical Products Administration , Chief Strategy Officer , Pulnovo Medical , Jessie Lian ,

Pulnovo Medical Raises Tens of Millions Dollars Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time! ....

Orbimed Healthcare Fund Management , National Medical Products Administration , Pulnovo Medical , From Operating Table , Yuanbio Venture Capital , Cenova Capital , Lilly Asia Ventures , Gaorong Capital , Huihe Capital , Pulmonary Artery Denervation , Global Trial ,

Pulmonary artery denervation is a promising treatment for pulmonary arterial hypertension: PADN-CFDA study

China: In patients with stable pulmonary arterial hypertension (PAH), pulmonary artery denervation (PADN) was safe and improved exercise capacity, clinical outcomes, and hemodynamics during the. ....

Coll Cardiol Cardiovasc , Division Of Cardiology , First Hospital Of Nanjing Medical University , Chang Zhang , Nanjing First Hospital , Nanjing Medical University , Pulmonary Arterial Pressure , Pulmonary Vascular Resistance , Pulmonary Artery Denervation , Pulmonary Arterial Hypertension , Exercise Capacity , Hosphodiesterase 5 Inhibitor ,

TCT2022| Pulnovo Medical Announced That The Latest Results Of PADN-CFDA Pivotal Trial Indicate Effectiveness And Safety of PADN For The Treatment Of Pulmonary Arterial Hypertension (PAH)

/PRNewswire/ Pulnovo Medical Limited, a globally recognized OTM platform, today announced the positive results from the Pulmonary Artery Denervation. ....

United States , Chen Shaoliang , Prnewswire Pulnovo Medical , Medical Limited , Pulmonary Artery Denervation , Professor Chen Shaoliang , Pulnovo Medical ,